CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 252 filers reported holding CYTOKINETICS INC in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,351,595 | -8.8% | 45,879 | +1.0% | 0.08% | -6.2% |
| Q2 2023 | $1,481,992 | +5.1% | 45,432 | +13.4% | 0.08% | -8.0% |
| Q1 2023 | $1,410,204 | +442.9% | 40,074 | +606.9% | 0.09% | +411.8% |
| Q4 2022 | $259,754 | -14.0% | 5,669 | -9.2% | 0.02% | -22.7% |
| Q3 2022 | $302,000 | +33.0% | 6,243 | +8.3% | 0.02% | +57.1% |
| Q2 2022 | $227,000 | -9.9% | 5,766 | -15.9% | 0.01% | +27.3% |
| Q1 2022 | $252,000 | -27.0% | 6,855 | -9.5% | 0.01% | 0.0% |
| Q4 2021 | $345,000 | +21.5% | 7,571 | -4.9% | 0.01% | +10.0% |
| Q3 2021 | $284,000 | +186.9% | 7,958 | -20.7% | 0.01% | +150.0% |
| Q3 2018 | $99,000 | +8.8% | 10,029 | -8.8% | 0.00% | 0.0% |
| Q2 2018 | $91,000 | – | 10,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |